Circulating natural killer cells in psoriasis

British Journal of Dermatology

Volumn 149, Issue 1, 2003, Pages 160-164

  Cameron, A L ^a   Kirby, Brian ^a   Griffiths, C E M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Autoimmunity; Innate immunity; Natural killer cells; Natural killer T cells; Psoriasis

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; CELL MARKER; LYMPHOCYTE ANTIGEN;

ADULT; ANTIBODY LABELING; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; BLOOD; CELL COUNT; CELL ISOLATION; CELL LABELING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PATHOGENESIS; PHLEBOTOMY; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; T LYMPHOCYTE;

ADULT; AUTOIMMUNE DISEASES; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS;

EID: 0041633632     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05319.x     Document Type: Article

References (31)

1. Griffiths CEM, Voorhees JJ. Psoriasis, T cells and autoimmunity. J R Soc Med 1996; 89: 315-19.
2. Valdimarsson H, Baker BS, Jonsdottir I et al. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal super-antigens? Immunol Today 1995; 16: 145-9.
3. Schlaak JF, Buslau M, Jochum W et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994; 102: 145-9.
4. Yawalkar N, Karlen S, Hunger R et al. Expression of interleukin-12 is increased m psoriatic skin. J Invest Dermatol 1998; 111: 1053-7.
5. Camp RDR, Vekony MA. Antigen receptor β-chain variable region usage by CD4+ and CD8+ T cells in psoriasis. J Invest Dermatol 1998; 110: 987-8.
6. Chang JCC, Smith LR, Froning JK et al. CD8+ T cells in psoriatic lesions preferentially use T cell receptor Vβ3 and/or Vβ13.1 genes. Proc Natl Acad Sci USA 1994; 91: 9282-6.
7. Menssen A, Trommler P, Vollmer S et al. Evidence for an antigen specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 1995; 155: 4078-83.
8. Berner B, Akca D, Jung T et al. Analysis of Th1 and Th2 expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 2000; 27: 1128-35.
9. Karpuj MV, Steinman L, Oksenberg JR. Multiple sclerosis: a polygenic disease involving epistatic interactions, germline rearrangements and environmental effects. Neurogenetics 1997; 1: 21-8.
10. Kukreja A, MacLaren NK. Autoimmunity and diabetes. J Clin Endocrin Metab 1999; 1: 4371-8.
11. Akakoshi M, Nakashima H, Tanaka Y et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1644-88.
12. Armstrong RD, Panayi GS. Natural killer cell activity in inflammatory joint disease. Clin Rheumatol 1983; 2: 243-9.
13. Kastrukoff LF, Morgan NG, Zecchini D et al. A role for natural killer cells in the immunopathogenesis of multiple sclerosis. J Neuroimmunol 1998; 86: 123-33.
14. Negishi K, Waldeck N, Chandy G et al. Natural kilier cell and islet cell activities in type I (insulin dependent) diabetes. Diabetologica 1986; 29: 352-7.
15. Sibbitt WL Jr, Bankhurst AD. Natural killer cells in connective tissue disorders. Clin Rheum Dis 1985; 11: 507-21.
16. Lanier LL. The origin and functions of natural killer cells. Clin Immunol 2000; 95: S14-18.
17. Seaman WE. Natural killer and natural killer T cells. Arthritis Rheum 2000; 43: 1204-17.
18. Elewaut D, Kronenberg M. Molecular biology of NK-T cell specificity and development. Semin Immunol 2000; 12: 561-8.
19. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
20. Majewski S, Wasik M, Jablonska S et al. Defective natural-killerand killer-cell activity associated with increased polymorphonuclear leukocyte adherence in psoriasis. Arch Dermatol Res 1986; 278: 264-9.
21. Jones CD, Guckian M, el-Ghorr AA et al. Effects of phototherapy on the production of cytokines by peripheral blood mononuclear cells and on systemic antibody responses in patients with psoriasis. Photodermatol Photoimmunol Photomed 1996; 12: 204-10.
22. Gilmour JW, Vestey JP, Norval M. The effect of UV therapy on immune function in patients with psoriasis. Br J Dermatol 1993; 129: 28-38.
23. Nickoloff BJ, Wrone-Smith T, Bonish B, Porcelli SA. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol 1999; 135: 546-52.
24. Cameron AL, Kirby B, Griffiths CEM. The role of natural killer cells in psoriasis. Br J Dermatol 2000; 142: 617-18 (Abstr.).
25. Mieza MA, Itoh T, Cui JQ et al. Selective reduction of V alpha 14+ NK-T cells associated with disease development in autoimmune mice. J Immunol 1996; 156: 4035-40.
26. Zhang B, Yamamura T, Kondo T et al. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997; 186: 1677-87.
27. Fort MM, Leach MW, Rennick DM. A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J Immunol 1998; 161: 3256-61.
28. Nickoloff BJ, Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 1999; 155: 145-58.
29. Hussain MJ, Alviggi L, Millward BA et al. Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined. Diabetologia 1987; 30: 907-11.
30. Cheng L, Zhang SZ, Xiao CY et al. The A5.1 allele of the major histocompatibility complex class I chain-related gene A is associated with psoriasis vulgaris in Chinese. Br J Dermatol 2000; 143: 324-9.
31. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727-9.